GM-CSF producing autoreactive CD4 + T cells in type 1 diabetes

Jan Knoop, Anita Gavrisan, Denise Kuehn, Julia Reinhardt, Melanie Heinrich, Markus Hippich, Anne Eugster, Christian Ockert, Anette Gabriele Ziegler, Ezio Bonifacio

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

The phenotype of autoreactive T cells in type 1 diabetes is described as Th1, Th17 and/or Th21, but is largely uncharacterized. We combined multi-parameter cytokine profiling and proliferation, and identified GM-CSF producing cells as a component of the response to beta cell autoantigens proinsulin and GAD65. Overall cytokine profiles of CD4 + T cell were not altered in type 1 diabetes. In contrast, patients with recent onset type 1 diabetes had increased frequencies of proinsulin-responsive CD4 + CD45RA T cells producing GM-CSF (p = 0.002), IFNγ (p = 0.004), IL-17A (p = 0.008), IL-21 (p = 0.011), and IL-22 (p = 0.007), and GAD65-responsive CD4 + CD45RA T cells producing IL-21 (p = 0.039). CD4 + T cells with a GM-CSF + IFNγ IL-17A IL-21 IL-22 phenotype were increased in patients for responses to both proinsulin (p = 0.006) and GAD65 (p = 0.037). GM-CSF producing T cells are a novel phenotype in the repertoire of T helper cells in type 1 diabetes and consolidate a Th1/Th17 pro-inflammatory pathogenesis in the disease.

Original languageEnglish
Pages (from-to)23-30
Number of pages8
JournalClinical Immunology
Volume188
DOIs
StatePublished - Mar 2018

Keywords

  • Autoreactive T cells
  • Cytokines
  • GM-CSF
  • Memory CD4 T cell
  • TH1 immunity
  • Type 1 diabetes

Fingerprint

Dive into the research topics of 'GM-CSF producing autoreactive CD4 + T cells in type 1 diabetes'. Together they form a unique fingerprint.

Cite this